TG Therapeutics (TGTX) Earnings Date, Estimates & Call Transcripts → I have a unique way to “hijack” the stock market. (From DTI) (Ad) Free tgtx Stock Alerts $14.30 +0.20 (+1.42%) (As of 10:21 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 6EstimatedActual EPS (Feb. 28) -$0.09 Beat By $0.03 Consensus EPS (Feb. 28) -$0.12 Read Call TranscriptListen to Call Get TG Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for TGTX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueTGTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TGTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad The Bull ReportHealthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic TG Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.02)($0.02)($0.02)Q2 20242($0.08)($0.06)($0.07)Q3 20242($0.05)($0.04)($0.05)Q4 20242($0.02)($0.02)($0.02)FY 20248($0.17)($0.14)($0.16)TGTX Earnings Date and InformationTG Therapeutics last announced its quarterly earnings data on February 28th, 2024. The biopharmaceutical company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.03. The company earned $43.97 million during the quarter, compared to analysts' expectations of $40.06 million. TG Therapeutics has generated $0.02 earnings per share over the last year ($0.02 diluted earnings per share) and currently has a price-to-earnings ratio of 705.4. Earnings for TG Therapeutics are expected to grow in the coming year, from ($0.12) to $0.57 per share. TG Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 6th, 2024 based off prior year's report dates.Read More TG Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/6/2024Estimated)------- 2/28/2024Q4 2023($0.12)($0.09)+$0.03($0.09)$40.06 million$43.97 million 11/1/2023Q3 2023$0.29$0.73+$0.44$0.73$23.91 million$165.80 million 8/1/2023Q2 2023($0.26)($0.34)($0.08)($0.34)$17.39 million$16.07 million 5/1/2023Q1 2023($0.36)($0.28)+$0.08($0.28)$3.38 million$7.80 million 2/28/2023Q4 2022($0.26)($0.39)($0.13)($0.39)$0.04 million$0.08 million11/10/2022Q3 2022($0.33)($0.26)+$0.07($0.26)$3.37 million$0.09 million Get the Latest News and Ratings for TGTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TG Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q2 2022($0.49)($0.30)+$0.19($0.30)$0.09 million$0.59 million5/10/2022Q1 2022($0.55)($0.51)+$0.04($0.51)$1.54 million$2.02 million3/1/2022Q4 2021($0.62)($0.70)($0.08)($0.70)$9.90 million$2.32 million 11/4/2021Q3 2021($0.56)($0.65)($0.09)($0.65)$3.23 million$2.03 million 8/1/2021Q2 2021($0.48)($0.59)($0.11)($0.59)$3.69 million$1.55 million 5/10/2021Q1 2021($0.52)($0.69)($0.17)($0.69)$0.99 million$0.79 million TG Therapeutics Earnings - Frequently Asked Questions When is TG Therapeutics's earnings date? TG Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 6th, 2024 based off last year's report dates. Learn more on TGTX's earnings history. Did TG Therapeutics beat their earnings estimates last quarter? In the previous quarter, TG Therapeutics (NASDAQ:TGTX) reported ($0.09) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.12) by $0.03. Learn more on analysts' earnings estimate vs. TGTX's actual earnings. How can I listen to TG Therapeutics's earnings conference call? The conference call for TG Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read TG Therapeutics's conference call transcript? The conference call transcript for TG Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does TG Therapeutics generate each year? TG Therapeutics (NASDAQ:TGTX) has a recorded annual revenue of $233.66 million. How much profit does TG Therapeutics generate each year? TG Therapeutics (NASDAQ:TGTX) has a recorded net income of $12.67 million. TGTX has generated $0.02 earnings per share over the last four quarters. What is TG Therapeutics's price-to-earnings ratio? TG Therapeutics (NASDAQ:TGTX) has a trailing price-to-earnings ratio of 705.35. What is TG Therapeutics's EPS forecast for next year? TG Therapeutics's earnings are expected to grow from ($0.12) per share to $0.57 per share in the next year. More Earnings Resources from MarketBeat Related Companies: Rocket Pharmaceuticals Earnings Date Dyne Therapeutics Earnings Date Keros Therapeutics Earnings Date Arvinas Earnings Date Maravai LifeSciences Earnings Date Rhythm Pharmaceuticals Earnings Date Vera Therapeutics Earnings Date Amphastar Pharmaceuticals Earnings Date Merus Earnings Date Geron Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:TGTX) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TG Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.